Holen Sie sich die Stockscreener-App
16.02
0.12%
-0.02
Handel nachbörslich:
16.02
Finanzdaten der Monte Rosa Therapeutics Inc-Aktie (GLUE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
44.95%
12.77
|
23.19 | 84.93 | 60.65 | 9.216 |
Operating Expenses
|
18.05%
45.74
|
38.75 | 40.89 | 47.64 | 35.74 |
| Benefits Costs and Expenses |
25.48%
43.03
|
34.29 | 37.22 | 45.05 | 33.00 |
| Costs And Expenses |
25.48%
43.03
|
34.29 | 37.22 | 45.05 | 33.00 |
| Operating Income/Loss |
112.00%
-32.98
|
-15.55 | 44.04 | 13.00 | -26.53 |
| Nonoperating Income/Loss |
39.05%
2.717
|
4.458 | 3.671 | 2.597 | 2.739 |
| Income/Loss From Continuing Operations Before Tax |
172.69%
-30.26
|
-11.10 | 47.71 | 15.60 | -23.79 |
| Income Tax Expense/Benefit |
364.97%
-3.177
|
1.199 | 0.822 | 2.164 | 0.071 |
| Income/Loss From Continuing Operations After Tax |
120.26%
-27.08
|
-12.29 | 46.88 | 13.44 | -23.86 |
|
Net Income/Loss
|
120.26%
-27.08
|
-12.29 | 46.88 | 13.44 | -23.86 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.26%
82.40
|
82.19 | 82.15 | 2.7364 | 82.01 |
| Diluted Average Shares |
0.26%
82.40
|
82.19 | 82.96 | 2.7364 | 82.01 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):